Global Poliovirus Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Poliovirus Vaccine market size was valued at US$ 694.4 million in 2023. With growing demand in downstream market, the Poliovirus Vaccine is forecast to a readjusted size of US$ 949 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Poliovirus Vaccine market. Poliovirus Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Poliovirus Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Poliovirus Vaccine market.
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Poliovirus Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Poliovirus Vaccine market. It may include historical data, market segmentation by Type (e.g., Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Poliovirus Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Poliovirus Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Poliovirus Vaccine industry. This include advancements in Poliovirus Vaccine technology, Poliovirus Vaccine new entrants, Poliovirus Vaccine new investment, and other innovations that are shaping the future of Poliovirus Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Poliovirus Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Poliovirus Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Poliovirus Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Poliovirus Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Poliovirus Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Poliovirus Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Poliovirus Vaccine market.
Market Segmentation:
Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Poliovirus Vaccine market?
What factors are driving Poliovirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poliovirus Vaccine market opportunities vary by end market size?
How does Poliovirus Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Poliovirus Vaccine market size was valued at US$ 694.4 million in 2023. With growing demand in downstream market, the Poliovirus Vaccine is forecast to a readjusted size of US$ 949 million by 2030 with a CAGR of 4.6% during review period.
The research report highlights the growth potential of the global Poliovirus Vaccine market. Poliovirus Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Poliovirus Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Poliovirus Vaccine market.
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Poliovirus Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Poliovirus Vaccine market. It may include historical data, market segmentation by Type (e.g., Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Poliovirus Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Poliovirus Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Poliovirus Vaccine industry. This include advancements in Poliovirus Vaccine technology, Poliovirus Vaccine new entrants, Poliovirus Vaccine new investment, and other innovations that are shaping the future of Poliovirus Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Poliovirus Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Poliovirus Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Poliovirus Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Poliovirus Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Poliovirus Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Poliovirus Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Poliovirus Vaccine market.
Market Segmentation:
Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
What is the 10-year outlook for the global Poliovirus Vaccine market?
What factors are driving Poliovirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poliovirus Vaccine market opportunities vary by end market size?
How does Poliovirus Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poliovirus Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Poliovirus Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Poliovirus Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Poliovirus Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Poliovirus Vaccine Sales by Type
2.3.1 Global Poliovirus Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Poliovirus Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Poliovirus Vaccine Sale Price by Type (2019-2024)
2.4 Poliovirus Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Poliovirus Vaccine Sales by Application
2.5.1 Global Poliovirus Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Poliovirus Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Poliovirus Vaccine Sale Price by Application (2019-2024)
3 GLOBAL POLIOVIRUS VACCINE BY COMPANY
3.1 Global Poliovirus Vaccine Breakdown Data by Company
3.1.1 Global Poliovirus Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Poliovirus Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Poliovirus Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Poliovirus Vaccine Revenue by Company (2019-2024)
3.2.2 Global Poliovirus Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Poliovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Poliovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poliovirus Vaccine Product Location Distribution
3.4.2 Players Poliovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLIOVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Poliovirus Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Poliovirus Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Poliovirus Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Poliovirus Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Poliovirus Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Poliovirus Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Poliovirus Vaccine Sales Growth
4.4 APAC Poliovirus Vaccine Sales Growth
4.5 Europe Poliovirus Vaccine Sales Growth
4.6 Middle East & Africa Poliovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Poliovirus Vaccine Sales by Country
5.1.1 Americas Poliovirus Vaccine Sales by Country (2019-2024)
5.1.2 Americas Poliovirus Vaccine Revenue by Country (2019-2024)
5.2 Americas Poliovirus Vaccine Sales by Type
5.3 Americas Poliovirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poliovirus Vaccine Sales by Region
6.1.1 APAC Poliovirus Vaccine Sales by Region (2019-2024)
6.1.2 APAC Poliovirus Vaccine Revenue by Region (2019-2024)
6.2 APAC Poliovirus Vaccine Sales by Type
6.3 APAC Poliovirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poliovirus Vaccine by Country
7.1.1 Europe Poliovirus Vaccine Sales by Country (2019-2024)
7.1.2 Europe Poliovirus Vaccine Revenue by Country (2019-2024)
7.2 Europe Poliovirus Vaccine Sales by Type
7.3 Europe Poliovirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poliovirus Vaccine by Country
8.1.1 Middle East & Africa Poliovirus Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Poliovirus Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Poliovirus Vaccine Sales by Type
8.3 Middle East & Africa Poliovirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poliovirus Vaccine
10.3 Manufacturing Process Analysis of Poliovirus Vaccine
10.4 Industry Chain Structure of Poliovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poliovirus Vaccine Distributors
11.3 Poliovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR POLIOVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Poliovirus Vaccine Market Size Forecast by Region
12.1.1 Global Poliovirus Vaccine Forecast by Region (2025-2030)
12.1.2 Global Poliovirus Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Poliovirus Vaccine Forecast by Type
12.7 Global Poliovirus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Poliovirus Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Poliovirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Poliovirus Vaccine Product Portfolios and Specifications
13.3.3 Bibcol Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Poliovirus Vaccine Product Portfolios and Specifications
13.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Poliovirus Vaccine Product Portfolios and Specifications
13.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Poliovirus Vaccine Product Portfolios and Specifications
13.6.3 IMBCA Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolios and Specifications
13.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Poliovirus Vaccine Product Portfolios and Specifications
13.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolios and Specifications
13.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Poliovirus Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Poliovirus Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Poliovirus Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Poliovirus Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Poliovirus Vaccine Sales by Type
2.3.1 Global Poliovirus Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Poliovirus Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Poliovirus Vaccine Sale Price by Type (2019-2024)
2.4 Poliovirus Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Poliovirus Vaccine Sales by Application
2.5.1 Global Poliovirus Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Poliovirus Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Poliovirus Vaccine Sale Price by Application (2019-2024)
3 GLOBAL POLIOVIRUS VACCINE BY COMPANY
3.1 Global Poliovirus Vaccine Breakdown Data by Company
3.1.1 Global Poliovirus Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Poliovirus Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Poliovirus Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Poliovirus Vaccine Revenue by Company (2019-2024)
3.2.2 Global Poliovirus Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Poliovirus Vaccine Sale Price by Company
3.4 Key Manufacturers Poliovirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poliovirus Vaccine Product Location Distribution
3.4.2 Players Poliovirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLIOVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Poliovirus Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Poliovirus Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Poliovirus Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Poliovirus Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Poliovirus Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Poliovirus Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Poliovirus Vaccine Sales Growth
4.4 APAC Poliovirus Vaccine Sales Growth
4.5 Europe Poliovirus Vaccine Sales Growth
4.6 Middle East & Africa Poliovirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Poliovirus Vaccine Sales by Country
5.1.1 Americas Poliovirus Vaccine Sales by Country (2019-2024)
5.1.2 Americas Poliovirus Vaccine Revenue by Country (2019-2024)
5.2 Americas Poliovirus Vaccine Sales by Type
5.3 Americas Poliovirus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poliovirus Vaccine Sales by Region
6.1.1 APAC Poliovirus Vaccine Sales by Region (2019-2024)
6.1.2 APAC Poliovirus Vaccine Revenue by Region (2019-2024)
6.2 APAC Poliovirus Vaccine Sales by Type
6.3 APAC Poliovirus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Poliovirus Vaccine by Country
7.1.1 Europe Poliovirus Vaccine Sales by Country (2019-2024)
7.1.2 Europe Poliovirus Vaccine Revenue by Country (2019-2024)
7.2 Europe Poliovirus Vaccine Sales by Type
7.3 Europe Poliovirus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Poliovirus Vaccine by Country
8.1.1 Middle East & Africa Poliovirus Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Poliovirus Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Poliovirus Vaccine Sales by Type
8.3 Middle East & Africa Poliovirus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poliovirus Vaccine
10.3 Manufacturing Process Analysis of Poliovirus Vaccine
10.4 Industry Chain Structure of Poliovirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poliovirus Vaccine Distributors
11.3 Poliovirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR POLIOVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Poliovirus Vaccine Market Size Forecast by Region
12.1.1 Global Poliovirus Vaccine Forecast by Region (2025-2030)
12.1.2 Global Poliovirus Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Poliovirus Vaccine Forecast by Type
12.7 Global Poliovirus Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Poliovirus Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Poliovirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Poliovirus Vaccine Product Portfolios and Specifications
13.3.3 Bibcol Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Poliovirus Vaccine Product Portfolios and Specifications
13.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Poliovirus Vaccine Product Portfolios and Specifications
13.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Poliovirus Vaccine Product Portfolios and Specifications
13.6.3 IMBCA Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolios and Specifications
13.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Poliovirus Vaccine Product Portfolios and Specifications
13.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolios and Specifications
13.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Poliovirus Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Poliovirus Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inactivated Polio Vaccine (IPV)
Table 4. Major Players of Oral Polio Vaccine (OPV)
Table 5. Global Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Poliovirus Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Poliovirus Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Poliovirus Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Poliovirus Vaccine Revenue by Application (2019-2024)
Table 13. Global Poliovirus Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Poliovirus Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Poliovirus Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Poliovirus Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Poliovirus Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Poliovirus Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Poliovirus Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Poliovirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Poliovirus Vaccine Products Offered
Table 22. Poliovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Poliovirus Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Poliovirus Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Poliovirus Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Poliovirus Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Poliovirus Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Poliovirus Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Poliovirus Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Poliovirus Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Poliovirus Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Poliovirus Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Poliovirus Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Poliovirus Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Poliovirus Vaccine
Table 58. Key Market Challenges & Risks of Poliovirus Vaccine
Table 59. Key Industry Trends of Poliovirus Vaccine
Table 60. Poliovirus Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Poliovirus Vaccine Distributors List
Table 63. Poliovirus Vaccine Customer List
Table 64. Global Poliovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Poliovirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Poliovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Poliovirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Poliovirus Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Poliovirus Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Poliovirus Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Poliovirus Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Poliovirus Vaccine Product Portfolios and Specifications
Table 80. Sanofi Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. GSK Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Poliovirus Vaccine Product Portfolios and Specifications
Table 85. GSK Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Bibcol Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Bibcol Poliovirus Vaccine Product Portfolios and Specifications
Table 90. Bibcol Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Bibcol Main Business
Table 92. Bibcol Latest Developments
Table 93. Serum Institute Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Poliovirus Vaccine Product Portfolios and Specifications
Table 95. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Tiantan Biological Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Tiantan Biological Poliovirus Vaccine Product Portfolios and Specifications
Table 100. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Tiantan Biological Main Business
Table 102. Tiantan Biological Latest Developments
Table 103. IMBCA Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCA Poliovirus Vaccine Product Portfolios and Specifications
Table 105. IMBCA Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. IMBCA Main Business
Table 107. IMBCA Latest Developments
Table 108. Panacea Biotec Ltd Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Panacea Biotec Ltd Poliovirus Vaccine Product Portfolios and Specifications
Table 110. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Panacea Biotec Ltd Main Business
Table 112. Panacea Biotec Ltd Latest Developments
Table 113. Bio-Med Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Med Poliovirus Vaccine Product Portfolios and Specifications
Table 115. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Bio-Med Main Business
Table 117. Bio-Med Latest Developments
Table 118. Halfkin Bio-Pharmaceuticals Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolios and Specifications
Table 120. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Halfkin Bio-Pharmaceuticals Main Business
Table 122. Halfkin Bio-Pharmaceuticals Latest Developments
Table 1. Poliovirus Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Poliovirus Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inactivated Polio Vaccine (IPV)
Table 4. Major Players of Oral Polio Vaccine (OPV)
Table 5. Global Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global Poliovirus Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Poliovirus Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global Poliovirus Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global Poliovirus Vaccine Revenue by Application (2019-2024)
Table 13. Global Poliovirus Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global Poliovirus Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Poliovirus Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global Poliovirus Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global Poliovirus Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Poliovirus Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global Poliovirus Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Poliovirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Poliovirus Vaccine Products Offered
Table 22. Poliovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Poliovirus Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Poliovirus Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Poliovirus Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Poliovirus Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Poliovirus Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Poliovirus Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Poliovirus Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Poliovirus Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Poliovirus Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Poliovirus Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC Poliovirus Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Poliovirus Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Poliovirus Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Poliovirus Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Poliovirus Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Poliovirus Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Poliovirus Vaccine
Table 58. Key Market Challenges & Risks of Poliovirus Vaccine
Table 59. Key Industry Trends of Poliovirus Vaccine
Table 60. Poliovirus Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Poliovirus Vaccine Distributors List
Table 63. Poliovirus Vaccine Customer List
Table 64. Global Poliovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Poliovirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Poliovirus Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Poliovirus Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Poliovirus Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Poliovirus Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Poliovirus Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Poliovirus Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Poliovirus Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Poliovirus Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Sanofi Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Poliovirus Vaccine Product Portfolios and Specifications
Table 80. Sanofi Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. GSK Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Poliovirus Vaccine Product Portfolios and Specifications
Table 85. GSK Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Bibcol Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Bibcol Poliovirus Vaccine Product Portfolios and Specifications
Table 90. Bibcol Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Bibcol Main Business
Table 92. Bibcol Latest Developments
Table 93. Serum Institute Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Poliovirus Vaccine Product Portfolios and Specifications
Table 95. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Tiantan Biological Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Tiantan Biological Poliovirus Vaccine Product Portfolios and Specifications
Table 100. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Tiantan Biological Main Business
Table 102. Tiantan Biological Latest Developments
Table 103. IMBCA Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCA Poliovirus Vaccine Product Portfolios and Specifications
Table 105. IMBCA Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. IMBCA Main Business
Table 107. IMBCA Latest Developments
Table 108. Panacea Biotec Ltd Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Panacea Biotec Ltd Poliovirus Vaccine Product Portfolios and Specifications
Table 110. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Panacea Biotec Ltd Main Business
Table 112. Panacea Biotec Ltd Latest Developments
Table 113. Bio-Med Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Med Poliovirus Vaccine Product Portfolios and Specifications
Table 115. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Bio-Med Main Business
Table 117. Bio-Med Latest Developments
Table 118. Halfkin Bio-Pharmaceuticals Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolios and Specifications
Table 120. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Halfkin Bio-Pharmaceuticals Main Business
Table 122. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Poliovirus Vaccine
Figure 2. Poliovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poliovirus Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Poliovirus Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Poliovirus Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 10. Product Picture of Oral Polio Vaccine (OPV)
Figure 11. Global Poliovirus Vaccine Sales Market Share by Type in 2023
Figure 12. Global Poliovirus Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Poliovirus Vaccine Consumed in Public
Figure 14. Global Poliovirus Vaccine Market: Public (2019-2024) & (K Units)
Figure 15. Poliovirus Vaccine Consumed in Private
Figure 16. Global Poliovirus Vaccine Market: Private (2019-2024) & (K Units)
Figure 17. Global Poliovirus Vaccine Sales Market Share by Application (2023)
Figure 18. Global Poliovirus Vaccine Revenue Market Share by Application in 2023
Figure 19. Poliovirus Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Poliovirus Vaccine Sales Market Share by Company in 2023
Figure 21. Poliovirus Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Poliovirus Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Poliovirus Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Poliovirus Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Poliovirus Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Poliovirus Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 72. Industry Chain Structure of Poliovirus Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Poliovirus Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Poliovirus Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Poliovirus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Poliovirus Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Poliovirus Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Poliovirus Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Poliovirus Vaccine
Figure 2. Poliovirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Poliovirus Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Poliovirus Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Poliovirus Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 10. Product Picture of Oral Polio Vaccine (OPV)
Figure 11. Global Poliovirus Vaccine Sales Market Share by Type in 2023
Figure 12. Global Poliovirus Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. Poliovirus Vaccine Consumed in Public
Figure 14. Global Poliovirus Vaccine Market: Public (2019-2024) & (K Units)
Figure 15. Poliovirus Vaccine Consumed in Private
Figure 16. Global Poliovirus Vaccine Market: Private (2019-2024) & (K Units)
Figure 17. Global Poliovirus Vaccine Sales Market Share by Application (2023)
Figure 18. Global Poliovirus Vaccine Revenue Market Share by Application in 2023
Figure 19. Poliovirus Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global Poliovirus Vaccine Sales Market Share by Company in 2023
Figure 21. Poliovirus Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Poliovirus Vaccine Revenue Market Share by Company in 2023
Figure 23. Global Poliovirus Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Poliovirus Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Poliovirus Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Poliovirus Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 34. Americas Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Poliovirus Vaccine Sales Market Share by Region in 2023
Figure 42. APAC Poliovirus Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 53. Europe Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Poliovirus Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Poliovirus Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Poliovirus Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2023
Figure 71. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 72. Industry Chain Structure of Poliovirus Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Poliovirus Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global Poliovirus Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Poliovirus Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Poliovirus Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Poliovirus Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Poliovirus Vaccine Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Single Use Centrifuge Systems Market Growth 2023-2029
US$ 3,660.00
February 2023
78 pages
Global Handheld Vital Signs Monitor Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Urethral Bulking System Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
89 pages
Global Swedish Porphyria Therapeutics Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
76 pages
Global Escitalopram Tablets Market Growth 2024-2030
US$ 3,660.00
October 2024
148 pages
